# Aumolertinib challenge as an optional treatment in advanced non small‑cell lung cancer after osimertinib failure with epidermal growth factor receptor‑sensitive mutation: A case series

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/aumolertinib-challenge-as-an-optional-treatment-in-advanced-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xinjing Ding,Jianghua Ding,Zhaohui Leng,Yun Song |
| Citations | 5 |
| DOI | 10.3892/ol.2022.13520 |
| Fields | Biochemistry, Genetics and Molecular Biology,Chemistry,Medicine |
| Open Access | true |
| OA Status | diamond |
| OA URL | https://www.spandidos-publications.com/10.3892/ol.2022.13520/download |
| OpenAlex ID | https://openalex.org/W4296642333 |
| PMID | 36276494 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Zhaohui Leng](https://scholariq.org/researchers/zhaohui-leng/)
- [Yun Song](https://scholariq.org/researchers/yun-song/)

## Paper journal

- [Oncology Letters](https://scholariq.org/journals/oncology-letters/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Quinazolinone synthesis and applications](https://scholariq.org/topics/quinazolinone-synthesis-and-applications/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.